Shenzhen YHLO Biotech CoSHSE:688575 +2.59%64 Pretax Margin % is 4.48% as of Mar. 2026, which is 71% below its 10-year median of 15.49. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.55 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks better than 56.36% on this metric.
The historical rank and industry rank for Shenzhen YHLO Biotech Co's Pretax Margin % or its related term are showing as below:
SHSE:688575'
s Pretax Margin % Range Over the Past 10 Years
Min: 2.59 Med: 15.49 Max: 29.81
Current: 5.79
SHSE:688575's Pretax Margin % is ranked better than 56.36% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs SHSE:688575: 5.79
Shenzhen YHLO Biotech Co (SHSE:688575) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Shenzhen YHLO Biotech Co Pretax Margin % Related Terms
Shenzhen YHLO Biotech Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688575 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen YHLO Biotech Co Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Shenzhen YHLO Biotech Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen YHLO Biotech Co (SHSE:688575) has a Pretax Margin % of 4.48% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Shenzhen YHLO Biotech Co and its competitors. This is 71% below median its historical median of 15.49. Over the past decade, Shenzhen YHLO Biotech Co's Pretax Margin % has ranged from 2.59 to 29.81. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #357 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 43.6%.
Is Shenzhen YHLO Biotech Co's Pretax Margin % too high?
Shenzhen YHLO Biotech Co's current Pretax Margin % of 4.48% is 71% below median its 10-year median of 15.49. Over the past 10 years, this metric has ranged from a low of 2.59 to a high of 29.81. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. Shenzhen YHLO Biotech Co's value of 4.48% is 78.8% above this industry median. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #357 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #357 out of 818 companies for Pretax Margin %. This puts Shenzhen YHLO Biotech Co in the upper half of its industry. The industry median Pretax Margin % is 2.51. Shenzhen YHLO Biotech Co's value of 4.48% is 78.8% above this benchmark. Historically, Shenzhen YHLO Biotech Co's own Pretax Margin % has ranged from 2.59 to 29.81 over the past decade. While the company's 10-year median is 15.49 vs. the industry median of 2.51, Shenzhen YHLO Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen YHLO Biotech Co's current Pretax Margin % of 4.48% is 78.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Shenzhen YHLO Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current Pretax Margin % is 4.48%, which is 71% below median its own 10-year median of 15.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.55, compared to a current price of ¥9.11 — trading 37.4% below its estimated fair value. The current Pretax Margin % is 4.48%, which is 71% below median its 10-year median of 15.49 and 78.8% above the Medical Devices & Instruments industry median of 2.51. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current Pretax Margin % is 4.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued.
The current stock price of ¥9.11 is trading 37.4% below its estimated GF Value™ of ¥14.55.
GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688575:
Pretax Margin %: 4.48% (71% below median its 10-year median of 15.49)
GF Value™: ¥14.55 vs. price of ¥9.11 (37.4% below fair value)
Industry Position: 78.8% above the Medical Devices & Instruments median (#357 of 818)
No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score
Get the complete analysis for SHSE:688575
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688575 has been successfully added to your 
